Medical geneticist and academician Ayşegül Kuşkucu, M.D., states that 10 percent of breast cancer cases are hereditary. Emphasizing that breast and ovarian cancer are inherited not only from female relatives but also from male relatives, Doctor Kuşkucu says “History of prostate cancer in father and close male relatives should provoke a high-index suspicion for hereditary cancer.”
Expressing that genetics play a role in all cancers, Lecturer Ayşegül Kuşkucu, M.D., Head of Medical Genetics Department of Yeditepe University Koşuyolu Hospital, highlights important details about correlation of cancer with genetics. Explaining the difference between genetic and hereditary cancer, Lecturer Ayşegül Kuşkucu, M.D., adds: “All cancers are genetic diseases, because a healthy body cell deviates from its normal course and transforms into a cancerous cell, when a gene that functions normally in the cell is somehow disrupted. In other words, a person is born and lives healthy, but changes in genes of certain tissues or organs lead to onset of cancer thereafter. However, hereditary means something different. In hereditary cancers, a child is born with some disorders in a certain group of genes, called mutation, and these mutations increase the risk of cancer when compared to healthy people; moreover, said gene mutation may transmit the risk of cancer to next generations. A very small part of cancers are hereditary. Approximately 10 percent of prevalent cancers are hereditary, such as breast cancer. We call them hereditary breast and ovarian cancers.”
Expressing that tumor suppressor genes usually play a role in hereditary cancers, Lecturer Ayşegül Kuşkucu, M.D., adds: “These genes function to suppress and prevent formation of any tumors in the body. However, certain mutations in tumor suppressor genes, such as BRCA1 and 2, may, sometimes, lead to certain unique cancers. These are breast and ovarian cancers. Mutation in these genes can be transmitted to next generations in the family. The mutation is carried by each cell of the body in the person with the mutation. Cancer can be detected in 3 tissues of the body, especially the prostate gland in men.”
Lecturer Kuşkucu, M.D., explains that not all BRCA mutations will lead to cancer; “One out of every 8 women is a candidate for breast cancer. This is an extremely high rate. However, we expect to detect the onset usually above the age of 40. On the other hand, it is necessary to act skeptically, if there is a family member with breast cancer that began around 30 years of age. Is there a predisposing environmental factor? Or, is there an inherited mutation? In such cases, it is necessary to act more carefully. A hereditary pattern seems more likely, if family history is notable for breast cancer at a younger age or breast cancer in more than one family member. If one carries the mutation, it does not necessarily mean that cancer will develop. It implies that the risk is higher in comparison to the general population and it is necessary to start follow-up at an earlier age. In families for whom hereditary cancer is suspected, the family member with documented cancer should, first, be assessed, if possible; if mutation is detected in the family member who was diagnosed with cancer, healthy family members are screened who are at risk. A tailored risk analysis is done for each family with the mutation. Therefore, one should absolutely visit a Medical Geneticist and genetic counseling should be requested.”
Clarifying that the history of prostate cancer in father and close male relatives (grandfather, paternal uncle, brothers, etc.) is also relevant for familial breast and ovarian cancers, Lecturer Kuşkucu, M.D., adds:
“The genes are thought to be passed on to the next generations only by women. However, father and paternal relatives are also likely inherit the mutations of genes. Therefore, both maternal and paternal histories should be reviewed well, if a hereditary cancer is suspected. For example; a hereditary cancer should be considered, if the father is diagnosed with prostate cancer and the paternal grandmother has history of ovarian cancer diagnosed at an earlier age. It is not possible to conclude that these cancers are always passed on by mother and maternal relatives. Hereditary cancers can be inherited by either parent and parental relatives. Therefore, it is necessary to question history of both maternal and paternal relatives for people who are considered at risk for breast cancer.”
Whether you live in Istanbul, across Turkey or around world, specialists at Yeditepe University Healthcare Institutions are available to review your medical records and provide an expert opinion on your diagnosis or treatment plan -without the need for an in- person visit.
Yeditepe University Healthcare Institutions collaborates with digital platforms via tele-medicine, to offer remote second opinions from Yeditepe University Healthcare Institutions in virtually every medical specialty. Having a second opinion can reassure you about a challenging diagnosis, or help you and your doctor plan the most appropriate course of treatment.
To have a medical second opinion, click here and complete the online form or call us on 009 0216 578 4 578
Making an appointmet at Yeditepe University Healthcare Institutions couldn't be easier, wheter you use your private medical insurance, pay for your own treatment ora re funded by third party.
As one of the region's leading independent private hospitals, we offer appointments with World class specialist and experts.
As an international patient, you will be you will be offered comprehensive service in the language of your choice right from your initial enquiry, through your medical treatment and, if necessary, help in liaising with your doctor in your home country upon your return home.
To book an appointment, click here and complete the online form or call us on 009 0216 578 4 578